A comparison of medroxyprogesterone serum concentrations by the oral or intramuscular route in patients with persistent or recurrent endometrial carcinoma-Reference-Cited by-同舟云学术

A comparison of medroxyprogesterone serum concentrations by the oral or intramuscular route in patients with persistent or recurrent endometrial carcinoma

Published:1979-11 Issue:5 Volume:135 Page:647-650
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Sall Sanford,DiSaia Philip,Morrow C. Paul,Mortel Rodrique,Prem Konald,Thigpen Tate,Creasman William

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference11 articles.

1. Discussion;Kelly,1951

2. Histologic effects of progestins on hyperplasia and carcinoma-in situ of the endometrium;Kistner;Cancer,1959

3. Progestational agents in the treatment of carcinoma of the endometrium;Kelly;N. Engl. J Med.,1961

4. Progestins in endometrial cancer;Kistner;surg. forum,1961

5. Clinical and histopathological evaluation of the effect of 17-alpha-hydroxy- progesterone, 17-N-caproate on endometrial cancer;Varga;Obstet. Gynecol.,1961

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormone-Responsive Cancers;Yen and Jaffe's Reproductive Endocrinology;2019

2. Hormone Responsive Cancers;Yen & Jaffe's Reproductive Endocrinology;2014

3. Hormonal therapy in advanced or recurrent endometrial cancer;Cochrane Database of Systematic Reviews;2010-12-08

4. Randomized evidence on chemotherapy and hormonal therapy regimens for advanced endometrial cancer: An overview of survival data;European Journal of Cancer;2006-02

5. Fertility-sparing therapy for young women with endometrial cancer;Expert Review of Anticancer Therapy;2006-01